Metaplanet's stock fell nearly 10% on Tuesday following a 7.5% drop on Monday, losing about 17% over two days after CEO Simon Gerovich's public note failed to reassure investors. The controversy centers on the company's Series 10 stock acquisition rights, which have diluted ordinary shareholders significantly due to an expanded pool of potential shares linked to equity raises funding Bitcoin purchases. Although the board froze the pool at over 319 million shares and added a lock-up, critics demand cancellation of the expanded rights and a new plan tied to the company's pivot to Bitcoin. Additionally, questions remain about Gerovich's indirect holdings via MMXX Ventures and past stock sales during the 2024 rally. Until these issues are addressed in detail, market skepticism is likely to persist, especially as Metaplanet's stock has fallen 85% from its 2025 peak and lagged behind Bitcoin and the Nikkei 225 this year.
Roivant Sciences saw its price target raised to $52 by Jefferies, reflecting a 24.7% potential gain, following positive Phase 2 trial results for mosliciguat, a drug treating pulmonary hypertension linked to interstitial lung disease. The trial showe...
EVI Industries reported Q4 revenue of $121.87 million, surpassing analyst expectations of $117.1 million, and achieved a record fiscal year revenue of $446.6 million, marking a 15% increase year-over-year. The company met earnings per share forecasts...
Lakeland Industries continues to face profitability challenges with a projected negative EPS of -$0.06 and recent unprofitability. However, the company secured important contracts with the Hong Kong Government Flying Service and Airports of Thailand,...
Intel's stock surged after Northland Securities upgraded it from "Market Perform" to "Outperform" with a $120 price target, following Intel Foundry's progress in High Numerical Aperture Extreme Ultraviolet (High-NA EUV) lithography. Intel has process...
ABM Industries reported strong Q3 2026 results, surpassing analyst EPS estimates with $1.04 per share versus the expected $1.01. The company achieved record revenue of $2.3 billion, a 4.2% increase driven by organic and acquisition growth. Adjusted n...
